Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®

被引：0
|
作者：
J. A. Kanis
H. Johansson
A. Oden
E. V. McCloskey
机构：
[1] University of Sheffield Medical School,WHO Collaborating Centre for Metabolic Bone Diseases
来源：
Osteoporosis International | 2011年 / 22卷 / 8期
关键词：
D O I：
10.1007/s00198-011-1683-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2357 / 2358
页数：1
相关论文
共 50 条
  • [1] A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
    J. A. Kanis
    H. Johansson
    A. Oden
    E. V. McCloskey
    Osteoporosis International, 2011, 22 : 2347 - 2355
  • [2] A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
    Kanis, J. A.
    Johansson, H.
    Oden, A.
    McCloskey, E. V.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (08) : 2347 - 2355
  • [3] A META-ANALYSIS OF THE EFFECT OF STRONTIUM RANELATE ON THE RISK OF VERTEBRAL AND NON-VERTEBRAL FRACTURE IN POSTMENOPAUSAL OSTEOPOROSIS: THE IMPACT OF SEVERE OSTEOPOROSIS AND CONTRAINDICATIONS
    Kanis, J. A.
    Johansson, H.
    Oden, A.
    McCloskey, E. V.
    Cooper, C.
    Rizzoli, R.
    Reginster, J-Y
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S120 - S121
  • [4] Strontium ranelate and non-vertebral fracture in postmenopausal osteoporosis
    Callejas Rubio, Jose Luis
    Lopez Perez, Lourdes
    Sanchez Cano, Daniel
    Ortego Centeno, Norberto
    MEDICINA CLINICA, 2006, 127 (07): : 279 - 279
  • [5] Strontium ranelate: vertebral and non-vertebral fracture risk reduction
    Seeman, Ego
    CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 : S17 - S20
  • [6] Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in Caucasian women with postmenopausal osteoporosis
    Adami, S
    Meunier, PJ
    Devogelaer, JP
    Hoszowski, K
    Fardellone, P
    Benhamou, V
    Brixen, K
    Bonidan, O
    Marcelli, C
    Reginster, JY
    Fechtenbaum, J
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S93 - S94
  • [7] Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Ortolani, S
    Badurski, J
    Kaufman, JM
    Spector, T
    Diez-Perez, A
    Seeman, E
    Lemmel, E
    Balogh, A
    Pors-Nielsen, S
    Phenekos, C
    Rizzoli, R
    Slosman, D
    Tupinon-Mathieu, I
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2002, 13
  • [8] The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Seeman, E
    Ortolani, S
    Badurski, JE
    Spector, TD
    Cannata, J
    Balogh, A
    Lemmel, EM
    Pors-Nielsen, S
    Rizzoli, R
    Genant, HK
    Reginster, JY
    Graham, J
    Ng, KW
    Prince, R
    Prins, J
    Seeman, E
    Wark, J
    Reginster, JY
    Devogelaer, JP
    Kaufman, JM
    Raeman, F
    Ziekenhuis, JP
    Walravens, M
    Pors-Nielsen, S
    Beck-Nielsen, H
    Charles, P
    Sorensen, OH
    Meunier, PJ
    Aquino, JP
    Benhamou, C
    Blotman, F
    Bonidan, O
    Bourgeois, P
    Dehais, J
    Fardellone, P
    Kahan, A
    Kuntz, JL
    Marcelli, C
    Prost, A
    Vellas, B
    Weryha, G
    Lemmel, EM
    Felsenberg, D
    Hensen, J
    Kruse, HP
    Schmidt, W
    Semler, J
    Stucki, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (05): : 459 - 468
  • [9] FRAX® AND THE EFFECT OF RALOXIFENE ON VERTEBRAL AND NON-VERTEBRAL FRACTURE
    McCloskey, E.
    Kanis, J.
    Johansson, H.
    Oden, A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 22 - 22
  • [10] FRAX and the effect of teriparatide on vertebral and non-vertebral fracture
    N. C. Harvey
    J. A. Kanis
    A. Odén
    R. T. Burge
    B. H. Mitlak
    H. Johansson
    E. V. McCloskey
    Osteoporosis International, 2015, 26 : 2677 - 2684
12345